<![CDATA[MRM Health 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=40942>Fri, 31 Jul 2026 05:11:07 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[MRM Health Strengthens Board with Michel Detheux as Chairman and Hans-Jürgen Wörle as Independent Director as MH002 Advances Through Phase 2b]]>https://www.newswire.co.kr/newsRead.php?no=1037428Fri, 26 Jun 2026 11:30:00 +0900<![CDATA[MRM 헬스, MH002 임상 2b상 진행 중 미셸 드퇴 이사회 의장·한스-위르겐 뵐를 사외이사 선임으로 이사회 강화]]>https://www.newswire.co.kr/newsRead.php?no=1037430Fri, 26 Jun 2026 11:30:00 +0900<![CDATA[MRM Health’s Lead Candidate MH002 Granted Fast Track Designation by U.S. FDA for the Treatment of Mild-to-Moderate Ulcerative Colitis]]>https://www.newswire.co.kr/newsRead.php?no=1033666Sun, 03 May 2026 16:00:00 +0900<![CDATA[MRM 헬스, 선도 후보물질 ‘MH002’로 경증-중등도 궤양성 대장염 치료제 미국 FDA 패스트트랙 지정 획득]]>https://www.newswire.co.kr/newsRead.php?no=1033667Sun, 03 May 2026 16:00:00 +0900<![CDATA[MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors]]>https://www.newswire.co.kr/newsRead.php?no=996617Tue, 10 Sep 2024 16:11:51 +0900<![CDATA[MRM Health to Present Positive Clinical Data from MH002 in Ulcerative Colitis at Digestive Disease Week (DDW)]]>https://www.newswire.co.kr/newsRead.php?no=989793Thu, 16 May 2024 10:03:07 +0900<![CDATA[MRM Health Initiates Clinical Research in Parkinson’s Disease]]>https://www.newswire.co.kr/newsRead.php?no=984538Wed, 21 Feb 2024 09:30:00 +0900<![CDATA[MRM 헬스, 파킨슨병 임상 연구 시작]]>https://www.newswire.co.kr/newsRead.php?no=984541Wed, 21 Feb 2024 09:30:00 +0900<![CDATA[MRM Health Appoints Katja Conrath as Chief Scientific Officer]]>https://www.newswire.co.kr/newsRead.php?no=968302Wed, 07 Jun 2023 16:20:37 +0900<![CDATA[MRM Health Completes Patient Recruitment in Ulcerative Colitis Study, Secures Financing and Provides Outlook for 2023]]>https://www.newswire.co.kr/newsRead.php?no=962786Tue, 07 Mar 2023 17:24:49 +0900<![CDATA[MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program]]>https://www.newswire.co.kr/newsRead.php?no=957829Tue, 13 Dec 2022 17:14:27 +0900<![CDATA[MRM Health Starts Clinical Trial with Next-Generation Optimized Consortium Therapeutic MH002 in Pouchitis]]>https://www.newswire.co.kr/newsRead.php?no=947151Thu, 30 Jun 2022 10:55:00 +0900